Effects of Osteopathic Manipulative Treatment (OMT) on Lower Extremity Muscle Characteristics in Parkinson’s Disease (PD) Patients
Objective: To define the mechanism of Osteopathic Manipulative Treatment (OMT) in decreasing symptomology and improving gait in Parkinson’s Disease (PD) patients. Background: A key symptom…Selective subthalamic DBS improved non-motor disorders without affecting weight gain in parkinsonism
Objective: Evaluate the impact of subthalamic nucleus deep brain stimulation (STN-DBS) on weight gain in Parkinsonian rats: The primary objective would be to determine whether…Lower plasma piperine levels in Parkinson’s disease: a PPMI metabolomics analysis
Objective: To explore piperine as a potential biomarker for Parkinson’s disease (PD) among GBA and LRRK2 mutation carriers and non-carriers. Background: Piperine is a yellow…Characteristics of Language Abnormalities in Multiple System Atrophy and Parkinson’s Disease
Objective: We characterized complex language profile and explore diagnostic potential of automated language analysis of natural spontaneous speech in differentiation between multiple system atrophy (MSA)…Progression of motor asymmetry in the MDS-UPDRS III in Parkinson’s Disease with and without REM Sleep Behavior Disorder over five years
Objective: To compare progression of motor asymmetry using the MDS-UPDRS-III in Parkinson’s Disease (PD) with and without probable REM Sleep Behavior disorder (pRBD) over 5…Association between Kinetic Parameters of Alpha-synuclein Seed Amplification Assay in CSF and Parkinson’s Disease Subtypes.
Objective: To assess differences in kinetics parameters of the αSyn seeding amplification assays in CSF (CSF-αSyn-SAA) in Parkinson’s Disease (PD) subtypes based on the presence…The Challenges of Very Late-Onset Parkinson’s Disease: Perspectives from Patients, Primary Caregivers and Attending Physicians.
Objective: The purpose of this study is to investigate the difficulties faced by very late-onset patients with Parkinson’s disease (PD), caregivers and attending physicians, and…The impact of cognitive impairment and Alzheimer’s disease neuropathological changes on gait and falls in Parkinson’s disease
Objective: To investigate the association between clinical markers of cognitive impairment, severity, and distribution of Alzheimer's disease neuropathological changes (ADNC) with gait difficulties, freezing of…Detecting Mild Cognitive Impairment in Parkinson’s Disease using Speech Markers
Objective: To identify speech acoustic measures associated with mild cognitive impairment in PD (PD-MCI). Background: Detection of PD-MCI is a challenge for clinical care and…“This Abstract Presents the Most Important Scientific ___.” A New Sentence Completion Test for Parkinson’s Disease.
Objective: In this study we examined psychometric properties of a brief language and executive function measure in People with Parkinson’s (PwP) and related disorders. Background:…
- « Previous Page
- 1
- …
- 178
- 179
- 180
- 181
- 182
- …
- 436
- Next Page »